Emon Elboudwarej (Emon Elboudjwarej)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Top Venues

Clinical and translational science

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yohann Loriot, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Petros D Grivas, Aude Flechon, Rohit K Jain, Umang Swami, Manojkumar Bupathi, Philippe Barthélémy, Philippe Beuzeboc, Phillip L Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Julia Tonelli, Mitch Sierecki, Marianna Zavodovskaya, Emon Elboudwarej, Lauri Diehl, Juliane M Jürgensmeier, Scott T Tagawa
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai-Wen Lin, Emon Elboudwarej, Ann Ran-Ran Qin, Christian Schwabe, Michelle R Kuhne, Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants. Clinical and translational science 17 (8) (2024)
Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai-Wen Lin, Emon Elboudwarej, Ann Ran-Ran Qin, Christian Schwabe, Michelle R Kuhne, Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants. Clinical and translational science 17 (8) (2024)
Kai Song, Emon Elboudwarej, Xi Zhao, Luting Zhuo, David Pan, Jinfeng Liu, Carrie Brachmann, Scott D Patterson, Oh Kyu Yoon, Marianna Zavodovskaya
RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples. PloS one 18 (10) (2023)